Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT00061659
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class
Conditions
Sarcoma, Soft Tissue
Interventions
DRUG:
ABT-510 - Thrombospondin-1 mimetic
Sponsor
Abbott